Anti-CD20 Monoclonal Antibody (Rituximab) for Therapy of Mediastinal CD20-Positive Large B-Cell Non-Hodgkin Lymphoma with a Local Tumor Extension into the Lung of a 10-Year-Old Girl

2003 ◽  
Vol 20 (4) ◽  
pp. 339-344 ◽  
Author(s):  
Srdjana Čulić ◽  
Vida Čulić ◽  
Visnja Armanda ◽  
Dubravka Kuljiš ◽  
Valdi Pešutić-Pisac ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Local Tumor ◽  
Tumor Extension ◽  
Non Hodgkin Lymphoma ◽  
Anti Cd20 ◽  
Large B Cell

scholarly journals CD20 antibodies: type II to tango?

Blood ◽  
2012 ◽  
Vol 119 (22) ◽  
pp. 5061-5063 ◽  
Author(s):  
Marinus H. J. van Oers
Keyword(s):  
Monoclonal Antibody ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Type Ii ◽  
Non Hodgkin Lymphoma ◽  
Anti Cd20 ◽  
Intense Research ◽  
Cd20 Antibodies

Although the chimeric anti-CD20 monoclonal antibody (mAb) rituximab has revolutionized the treatment of B-cell non-Hodgkin lymphoma (NHL), still many patients relapse and an increasing number become refractory to rituximab-containing therapy. This has initiated intense research to develop more potent anti-CD20 antibodies.

A phase I trial of ublituximab (TG-1101), a novel glycoengineered anti-CD20 monoclonal antibody (mAb) in B-cell non-Hodgkin lymphoma patients with prior exposure to rituximab.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8524-8524 ◽  
Author(s):  
Owen A. O'Connor ◽  
Changchun Deng ◽  
Jennifer Effie Amengual ◽  
Mazen Y. Khalil ◽  
Marshall T. Schreeder ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Phase I Trial ◽  
Prior Exposure ◽  
Non Hodgkin Lymphoma ◽  
Anti Cd20

Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-Hodgkin lymphoma

2011 ◽  
Vol 57 (2) ◽  
pp. 348-349 ◽  
Author(s):  
Elvis Terci Valera ◽  
Rosane Gomes Queiroz ◽  
María Sol Brassesco ◽  
Carlos Alberto Scrideli ◽  
Fábia Neves ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
B Cell ◽  
Residual Disease ◽  
Antibody Therapy ◽  
Disease Status ◽  
Monoclonal Antibody Therapy ◽  
Non Hodgkin Lymphoma ◽  
Anti Cd20 ◽  
Minimal Residual ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document